ivf In Vitro Fertilization

Loading............ Please wait
Over 3143 Units Worldwide    - The World's Largest IVF Directory www.IVF-Worldwide.com

Saturday, Sep 11, 2010
Home - The use of GnRH agonist in IVF protocols
back
The use of GnRH agonist in IVF protocols


The survey was compiled by Dr. Ilan Tur-Kaspa, President and Medical Director, Institute for Human Reproduction (IHR), Chicago, USA, and Prof. Bart Fauser, Head, Department of Obstetrics and Gynecology, University of Utrecht Medical Center, Utrecht, The Netherlands

Generic names: Buserelin, Goserelin, Luprorelin, Luprolide, Naferelin, Triptorelin
Histrelin, Deslorelin,

Trade names: Superecure, Superefact, Zoladex, Lupron depot, Prostap SR, Enantone, Lucrin depot, Trenantone-Gyn, Synarella, Synarel, Decapeptyl SR, Gonapeptyl

Since the first publication of  Porter et al. Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins, Lancet 1984;2:1284, there were several protocols that have been developed. This survey relates to current practice, opinions and therapeutic approaches to patient preparation for IVF using GnRH agonist.

The personal data requested aims only to assure the safety and authenticity of the data submitted. No personal data will be published.

Name
Name of IVF Center (Unit)
E-mail

1. Country


2. Estimated number of total IVF cycles performed by the unit annually


cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
cycles
3. Can you estimate the percentage of your patients receiving GnRH agonist per year?














4. Can you estimate the percentage of your patients receiving GnRH antagonist per year?














5. What are the reasons for giving a GnRH antagonist co-treatment in some patients?









6. When using a GnRH agonist, what type of preparation do you generally use?








7. Can you estimate the percentage of your patients that received Depot GnRH preparations?














8. Why use a Depot preparation?










9. If you use Depot GnRH agonists and the patients did not conceive, do you supplement the patients with estrogen to prevent a hypoestrogenic state?






10. What is the most common protocol that you use for GnRH agonist treatment?






11. If you use the long protocol, when do you start?






12. If you use the short protocol, how do you treat?






13. Can you estimate the percentage of your patients that received Daily (short acting) GnRH preparations for the Short Protocol (Flare-up Protocol)














14. If you use a daily preparation, do you cut the dose of the agonists by half when you start stimulation?






15. Do you monitor pituitary desensitization with?









16. In the case of a functioning ovarian cyst with elevated Estradiol levels, you would recommend:






17. In the case of a nonfunctioning ovarian cyst with normal Estradiol levels, you would recommend:






18. What is the starting dose of Gonadotropin with a long GnRH agonist protocol for normal responders less than 35 years of age, used in your clinic?







19. What is the starting dose of Gonadotropin with a long GnRH agonist protocol for normal responders 35-39 years of age, used in your clinic?







20. When endomterial thickness is less than 5 mm, do you have a cutoff for estradiol level to start stimulation?








21. Do you have age limits for using long down regulation protocols with GnRH agonists?







22. Do you use long down regulation protocols with GnRH agonists for poor responders?




23. With a long GnRH agonist protocol, do you routinely add recombinant-LH/hMG or hCG?










24. Do you add LH, or treat with hMG routinely in the older group of patients under the agonist protocol?







25. Do you add 6 days after OPU, for luteal support, one injection of daily dose of GnRH agonist?






If you have comments, please add here